Search Results 61-70 of 18088 for Parkinson's disease
... and may mimic those of Parkinson's disease and dementia. Symptoms get worse over time and may include: Stiffness, especially of the neck, and awkward movements.
But, a genetic mutation, known as GBA, that leads to early onset of Parkinson's disease and severe cognitive impairment (in about 4-7 percent of all patients ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
This study is being done to collect skin samples from people with and without neurodegenerative and vascular disorders including Parkinson's disease (PD), ...
Study to Evaluate the Pathophysiology of Multiple System Atrophy, Parkinson's Disease, Parkinson's Disease with Autonomic Failure and Dementia with Lewy Bodies ...
I regularly compete in Ironman and other triathlon events, road cycling events and mountain biking events. I live in the Dallas area with my wife, three boys ( ...
About this study. To learn more about the biomarkers for preclinical parkinson's disease. Participation eligibility. Participant eligibility includes age, ...
... Parkinson's disease and its potential as a target for neuroprotective therapies. It has also been the focus of multiple efforts to develop a molecule that ...
Dopamine agonists are a class of drugs that include pramipexole and ropinirole. They are commonly used to treat Parkinson's disease, but low doses also are used ...
Mayo Clinic's Parkinson's Disease Lab in Florida under the direction of Owen Ross, Ph.D., studies the genetic factors involved in Parkinson's disease.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The deadline to have twice the impact to advance healthcare research is May 15.